U-Blot® Research Grade TimigutuzumabCat. No. WA3664Request quote
Size: 50ug/100ug
Overview
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade TimigutuzumabCat. No. WA3664U-Blot® Research Grade TimdarpaceptCat. No. WA3663Request quote
Size: 50ug/100ug
U-Blot® Research Grade TilvestamabCat. No. WA3662Request quote
Size: 50ug/100ug
U-Blot® Research Grade tilrekimigCat. No. WA3661Request quote
Size: 50ug/100ug
U-Blot® Research Grade TilogotamabCat. No. WA3660Request quote
Size: 50ug/100ug
U-Blot® Research Grade TildrakizumabCat. No. WA3659Request quote
Size: 50ug/100ug
U-Blot® Research Grade TilavonemabCat. No. WA3658Request quote
Size: 50ug/100ug
U-Blot® Research Grade TilatamigCat. No. WA3657Request quote
Size: 50ug/100ug
U-Blot® Research Grade TigatuzumabCat. No. WA3656Request quote
Size: 50ug/100ug
U-Blot® Research Grade TifcemalimabCat. No. WA3655Request quote
Size: 50ug/100ug
U-Blot® Research Grade TidutamabCat. No. WA3654Request quote
Size: 50ug/100ug
U-Blot® Research Grade TicilimumabCat. No. WA3653Request quote
Size: 50ug/100ug
REQUEST A QUOTE
EMAILinfo@mail.ucallm.com
PHONE+(1)-866-986-9598
ONLINE FORMOnline Quote Submission
X+(1)-866-986-9598